Tolyporphin: A natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3571-3578

  Morlière, Patrice ^a   Mazière, Jean Claude ^b   Santus, René ^a,e   Smith, Charles D ^c   Prinsep, Michèle R ^d   Stobbe, Corinne C ^c   Fenning, Matthew C ^c   Golberg, Joanna L ^c   Chapman, J Donald ^c  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c FOX CHASE CANCER CENTER   (United States)

^d UNIVERSITY OF WAIKATO   (New Zealand)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(N BUTANOL) 6 PHEOPHORBAMIDE; 6 METHYLPYROPHEOPHORBIDE; NATURAL PRODUCT; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; TOLYPORPHIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; CYANOBACTERIUM; DRUG DISTRIBUTION; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PHOTOSENSITIVITY; PRIORITY JOURNAL; SCID MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS; COENZYME A-TRANSFERASES; CYANOBACTERIA; DIHEMATOPORPHYRIN ETHER; DRUG SCREENING ASSAYS, ANTITUMOR; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TUMOR CELLS, CULTURED;

EID: 0032529659     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pass, H. I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst., 85: 443-456, 1993.
2. Parrish, J. A. New concepts in therapeutic photomedicine: photochemistry, optical targeting and the therapeutic window. J. Invest. Dermatol., 77: 45-50, 1981.
3. Ben-Hur, E. Second-generation photosensitizers for photodynamic therapy of cancer. In: W. C. Dewey, M. Edington, R. J. M. Fry, E. J. Hall, and G. F. Whitmore (eds.), Radiation Research: A Twentieth-Century Perspective. San Diego: Academic Press, pp. 664-669, 1992.
4. Ris, H. B., Altermati, H. J., Nachbur, B., Stewart, J. C. M., Wang, Q., Lim, C. K., Bonnett, R., and Althaus, U. Intraoperative photodynamic therapy with meso-tetra-(hydroxyphenyl) chlorin for chest malignancies. Lasers Surg. Med., 18: 39-45, 1996.
5. Schuitmaker, J. J., Baas, P., Van Leegoed, H. L. L. M., van der Meulen, F. W., Star, W. M., and van Zandwijk, N. Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol. B Biol., 34: 3-12, 1996.
6. Smith, C. D., Prinsep, M. R., Caplan, F. R., Moore, R. E., and Patterson, G. M. L. Reversal of multiple drug resistance by tolyporphin, a novel cyanobacterial natural product. Oncol. Res., 6: 211-218, 1994.
7. Prinsep, M. R., Caplan, F. R., Moore, R. E., Patterson, G. M. L., and Smith, C. D. Tolyporphin, a novel multidrug resistance reversing agent from the blue-green alga Tolypothrix nodosa. J. Am. Chem. Soc., 114: 385-386, 1992.
8. Pandey, R. K., Bellnier, D. A., Smith, K. M., and Dougherty, T. J. Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem. Photobiol., 53: 65-72, 1991.
9. Dagan, A., Gatt, S., Cerbut-Karabat, S., Mazière, J. C., Mazière, C., Santus, R., Engelhardt, E. L., Yeh, K. A., Stobbe, C. C., Fenning, M. C., and Chapman, J. D. Uptake by cells and photosensitizing effectiveness of novel pheophorbide derivatives in vitro. Int. J. Cancer, 63: 831-839, 1995.
10. Chapman, J. D., Stobbe, C. C., Engelhardt, E. L., Fenning, M. C., Brown, D. Q., Dagan, A., and Gatt, S. E. Exploitation of interstitial brachytherapy techniques for PDT. II. Novel photosensitizers for the treatment of solid tumors. In: Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy III, Proceedings of the Society of Photo-Optical Instrumentation Engineers. 2133: 128-139, 1994.
11. Gèze, M., Gaullier, J. M., Bazin, M., and Santus, R. Sub-cellular localization of second generation PDT photosensitizers studied by microspectrofluorometry. In: E. Kohen and J. G. Hirschberg (eds.), Analytical Use of Fluorescent Probes in Oncology, pp. 113-121. New York: Plenum Press, 1996.
12. Rodgers, M. A. J. The photoproperties of porphyrins in model biological environments. In: G. Jori and C. Perria (eds.), Photodynamic Therapy of Tumors and Other Diseases, pp. 21-35. Padova, Italy: Libreria Progetto, 1985.
13. Chapman, J. D., Stobbe, C. C., Arnfield, M. R., Santus, R., Lee, J., and McPhee, M. S. Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. Radiat. Res., 126: 73-79, 1991.
14. Maier, K., Schmitt-Landgraf, R., and Siegemund, B. Development of an in vitro test system with human skin cells for evaluation of phototoxicity. Toxicol. in Vitro, 5: 457-461, 1991.
15. Lasarow, R. M., Isseroff, R. R., and Gomez, E. C. Quantitative in vitro assessment of phototoxicity by fibroblasts: Neutral Red assay. J. Invest. Dermatol., 98: 725-729, 1992.
16. Brown, M. S., Dana, S. E., and Goldstein, J. L. Cholesterol ester formation in cultured human fibroblasts: stimulation by oxygenated sterols. J. Biol. Chem., 250: 4025-4027, 1975.
17. Mazière, C., Mazière, J. C., Mora, L., Auclair, M., and Polonovski, J. Trifluoperazine increases fatty acid incorporation into phospholipid in cultured human fibroblasts. Lipids, 23: 419-423, 1988.
18. Mazière, C., Mazière, J. C., Mora, L., and Polonovski, J. Rapid analysis of cellular lipids without extraction. J. Biochem. Biophys. Methods, 14: 267-272, 1987.
19. Bazin, M., and Santus, R. Selective type 1 photooxidations in mixtures of porphyrins and electrophilic nitroimidazoles. Photochem. Photobiol., 43: 235-239, 1986.
20. Gèze, M., Morlière, P., Mazière, J. C., Smith, K. M., and Santus, R. Lysosomes, a key target of hydrophobic photosensitizes proposed for photochemotherapeutic applications. J. Photochem. Photobiol. B Biol., 20: 23-35, 1993.
21. Chapman, J. D., Stobbe, C. C., Arnfield, M. R., Santus, R., and McPhee, M. S. The effectiveness of short term versus long term exposures to Photofrin II in killing light-activated tumor cells. Radiat. Res., 128: 82-89, 1991.
22. Haugland, R. P. Cell-pemeant probes for the endoplasmic reticulum and Golgi apparatus. In: M. T. Z. Spence (ed.), Handbook of Fluorescent Probes and Research Chemicals, pp. 279-281. Eugene, OR: Molecular Probes, Inc., 1996.
23. Pagano, R. E., Martin, O. C., Kang, H. C., and Haugland, R. P. A novel fluorescent ceramide analogue for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor. J. Cell Biol., 113: 1267-1279, 1991.
24. Kohen, E., Santus, R., and Hirschberg, J. G. Photobiology, pp. 83-86, Orlando: Academic Press, 1995.
25. Moan, J., Streckyte, G., Bagdonas, S., Bech, O., and Berg, K. Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid. Int. J. Cancer, 70: 90-97, 1997.
26. Candide, C., Reyftmann, J. P., Santus, R., Mazière, J. C., Morlière, P., and Golstein, S. Modification of ∈-amino group of lysines, cholesterol oxidation and oxidized lipid-apoprotein cross-link formation by porphyrin-photosensitized oxidation of human low density lipoproteins. Photochem. Photobiol., 48: 137-146, 1988.
27. Candide, C., Mazière, J. C., Santus, R., Mazière, C., Morlière, P., Reyftmann, J. P., Goldstein, S., and Dubertret, L. Photosensitization of Wi26-VA4 transformed human fibroblasts by low density lipoprotein loaded with the anticancer porphyrin mixture photofrin II: evidence for endoplasmic reticulum alteration. Cancer Lett., 44: 157-161, 1989.
28. Bellnier, D. A., Henderson, B. W., Pandey, R. K., Potter, W. R., and Dougherty, T. J. Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a. J. Photochem. Photobiol. B Biol., 20: 55-61, 1993.
29. Pandey, R. K., Shiau, F-Y., Sumlin, A. B., Dougherty, T. J., and Smith, K. M. Structure/activity relationship among photosensitizers related to pheophorbides and bacteriopheophorbides. Bioorg. Med. Chem. Lett., 2: 491-496, 1992.
30. Berg, K. Mechanisms of cell damage in photodynamic therapy. In: A. Young, H. Honigsmann, and G. Jori (eds.), The Fundamental Bases of Phototherapy, pp. 181-207. Milan: OEMF, 1996.
31. Gèze, M., Morlière, P., Mazière, J-C., Smith, K. M., and Santus, R. Lysosomes, a key target of hydrophobic photosensitizers proposed for photochemotherapeutic applications. J. Photochem. Photobiol. B Biol., 20: 23-25, 1993.
32. Woodburn, K. W., Vardaxis, N. J., Hill, J. S., and Phillips, D. R. Subcellular localization of porphyrins using confocal laser scanning microscopy. Photochem. Photobiol., 54: 725-732, 1991.
33. Moan, J., and Berg, K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol., 53: 549-553, 1991.
34. Henderson, B. W., Bellnier, D. A., Greco, W. R., Sharma, A., Pandey, R. K., Vaughan, L. A., Weishaupt, K. R., and Dougherty, T. J. An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res., 57: 4000-4007, 1997.